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CDC and Florida Department of Health investigate a likely case of new 
variant Creutzfeldt Jakob disease in a U.K. citizen residing in the U.S.
Atlanta: The Florida Department of Health and the CDC are investigating a likely case of new variant Creutzfeldt 
Jakob disease (vCJD) in a 22-year-old citizen of the United Kingdom living in Florida. The clinical diagnosis was 
made at a hospital in the U.K and she has since returned to the U.S. Preliminary analysis of information provided 
by the U.K. indicates that the patient's clinical condition and history are consistent with vCJD acquired in the U.K. 
However, the only way to confirm a diagnosis of vCJD is through study of brain tissue obtained by a brain biopsy 
or at autopsy.
New variant C JD  is a rare, degenerative, fatal brain disorder that emerged in the U.K. in the mid-1990s. Although 
experience with this new disease is limited, evidence to date indicates that there has never been a case 
transmitted from person to person. Rather, the disease is thought to result from consumption of cattle products 
contaminated with an agent that causes a disease called bovine spongiform encephalopathy (BSE, commonly 
known as mad cow disease). To date, no case of this cattle disease has been identified in the United States by 
the USDA
If confirmed, this would be the first case of vCJD reported in a U.S. resident. However, because the disease is 
thought to have a long incubation period, CDC believes the patient acquired the disease while living in the U.K.
While very tragic, it was not unexpected that a case of vCJD would be identified in the United States in a person 
who had lived in countries experiencing BSE. O f the 125 vCJD patients worldwide, almost all had multiple-year 
exposures in the United Kingdom between 1980 and 1996 during the occurrence of a large UK outbreak of BSE 
among cattle. The risk of being exposed to BSE as a traveler in Europe is extremely small.
CDC received information yesterday, April 17, that this patient's illness was a likely case of vCJD and dispatched 
a medical epidemiologist who is working with the Florida Department of Health to gather more information.
New Variant CJD: Fact Sheet
New variant C JD  (vCJD) is a rare, degenerative, fatal brain disorder.
Although experience with this new disease is limited, evidence to date indicates that there has never been a case 
transmitted person to person.
As of April 2, 2002, a total of 125 cases of vCJD had been reported in the world: 117 from the United Kingdom, 
six from France, and one each from Ireland and Italy.
Almost all the 125 vCJD patients had multiple-year exposures in the United Kingdom between 1980 and 1996 
during the occurrence of a large UK outbreak of bovine spongiform encephalopathy (BSE, commonly known as 
mad cow disease) among cattle.
There has never been a case of vCJD that did not have a history of exposure within a country where this cattle 
disease, BSE, was occurring.
To date, despite an active USDA surveillance program, no case of this cattle disease has been identified in the 
United States.
It is believed that the persons who have developed vCJD became infected through their consumption of cattle 
products contaminated with the agent of BSE. There is no known treatment of vCJD and it is invariably fatal.
The vCJD should not be confused with the classic form of C JD  that is endemic throughout the world, including the 
United States. The median age at death of patients with classic C JD  in the United States, for example, is 68 
years, and very few cases occur in persons under 30 years of age. In contrast, the median age at death of 
patients with vCJD in the United Kingdom is 28 years.
The vCJD can be confirmed only through examination of brain tissue obtained by biopsy or at autopsy, but a 
“ probable case” of vCJD can be diagnosed on the basis of clinical criteria developed in the United Kingdom.
The incubation period for vCJD is unknown because it is a new disease. However, it is likely that ultimately this 
incubation period will be measured in terms of many years or decades. In other words, whenever a person 
develops vCJD from consuming a BSE-contaminated product, he or she likely would have consumed that product 
many years or a decade or more earlier.
In contrast to classic CJD, vCJD in the United Kingdom predominantly affects younger people, has atypical 
clinical features, with prominent psychiatric or sensory symptoms at the time of clinical presentation and delayed 
onset of neurologic abnormalities, including ataxia within weeks or months, dementia and myoclonus late in the 
illness, a duration of illness of at least 6 months, and a diffusely abnormal non-diagnostic electroencephalogram.
The BSE epidemic in the United Kingdom reached its peak incidence in January 1993 at almost 1,000 new cases 
per week. The outbreak may have resulted from the feeding of scrapie-containing sheep meat-and-bone meal to 
cattle. There is strong evidence and general agreement that the outbreak was amplified by feeding rendered 
bovine meat-and-bone meal to young calves.
The Centers for Disease Control and Prevention (CDC) monitors the trends and current incidence of C JD  in the 
United States by analyzing death certificate information from U.S. multiple cause-of-death data, compiled by the 
National Center for Health Statistics, CDC. By 4-year periods from 1987 through 1998, the average annual death 
rates of C JD  (not vCJD) have remained relatively constant, ranging from 0.98 cases per 1 million in 1987-1990 to 
1.03 cases per 1 million in 1995-1998. In addition, C JD  deaths in persons aged <30 years in the United States 
remain extremely rare (<5 cases per 1 billion per year). In contrast, in the United Kingdom, over half of the 
patients who died with vCJD were in this young age group.
In addition, CDC collects, reviews and when indicated, actively investigates reports by health care personnel or 
institutions of possible CJD  or vCJD cases. Also, in 1996-97, CDC established, in collaboration with the American
Association of Neuropathologists, the National Prion Disease Pathology Surveillance Center at Case Western 
Reserve University, which performs special diagnostic tests for prion diseases including post-mortem tests for 
vCJD.
Prevention measures
According to the Animal and Plant Health Inspection Service of the U.S. Department of Agriculture, BSE has not 
been detected in the United States, despite active surveillance efforts since May 1990. To prevent BSE from 
entering the United States, severe restrictions were placed on the importation of live ruminants, such as cattle, 
sheep and goats, and certain ruminant products from countries where BSE was known to exist. These restrictions 
were later extended to include importation of ruminants and certain ruminant products from all European 
countries.
It is extremely unlikely that BSE would be a foodborne hazard in this country. Because the use of ruminant tissue 
in ruminant feed was probably a necessary factor responsible for the BSE outbreak in the United Kingdom and 
because of the current evidence for possible transmission of BSE to humans, the U.S. Food and Drug 
Administration instituted a ruminant feed ban in June 1997 that became fully effective as of October 1997.
In late 2001, the Harvard Center for Risk Assessment concluded in its study of various scenarios involving BSE in 
the U.S., that the FDA ruminant feed rule provides a major defense against this disease.
BSE/TSE Action Plan of the Department of Health and Human Services (DHHS)
The BSE/TSE Action Plan of DHHS has four major components:
Surveillance for human disease is primarily the responsibility of CDC.
Protection is primarily the responsibility of the Food and Drug Administration (FDA).
Research is primarily the responsibility of the National Institutes of Health (NIH).
Oversight is primarily the responsibility of the Office of the Secretary of DHHS.
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
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